<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Relapse risk doubles in UC patients with histologic inflammation

minute read

by Healio | June 9, 2022
placeholder

“In this large, multicenter, real-world study including both academic and community practices using standard-of-care reports, histologic inflammation — despite endoscopic remission — independently conveyed a two-fold increased risk for subsequent relapse within a year,” Benjamin Click, assistant professor at the University of Colorado Crohn’s and Colitis Center and School of Medicine, told Healio.

Topics: Press Coverage